75291-84-8

Basic information

• Product Name: 5,6-DICHLORONICOTINAMIDE
• Synonyms: BUTTPARK 147\04-81;5,6-DICHLORONICOTINAMIDE;2 3-DICHLOROPYRIDINE-5-CARBOXAMIDE
• CAS NO: 75291-84-8
• Molecular Formula: C₆H₄Cl₂N₂O
• Molecular Weight: 191.01
• Mol File: 75291-84-8.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 300.9°C at 760 mmHg
• Flash Point: 135.8°C
• Appearance: /
• Density: 1.524g/cm³
• Vapor Pressure: 0.00109mmHg at 25°C
• Refractive Index: 1.603
• CAS DataBase Reference: 5,6-DICHLORONICOTINAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 5,6-DICHLORONICOTINAMIDE(75291-84-8)
• EPA Substance Registry System: 5,6-DICHLORONICOTINAMIDE(75291-84-8)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 75291-84-8(Hazardous Substances Data)

Usage

General Description

5,6-Dichloronicotinamide, also known as 5,6-DCN, is a chemical compound with the molecular formula C6H4Cl2N2O. It is an analog of niacinamide, a form of vitamin B3, and is used in the production of pharmaceuticals, dyes, and pesticides. 5,6-DCN is a white crystalline solid that is soluble in organic solvents and slightly soluble in water. It has been studied for its potential antimicrobial and antitumor properties and has also been investigated as a building block for the synthesis of various biologically active compounds. However, it is also known to be toxic to aquatic organisms and may cause skin and eye irritation in humans, so proper handling and disposal procedures should be followed when working with this chemical.

InChI:InChI=1/C6H4Cl2N2O/c7-4-1-3(6(9)11)2-10-5(4)8/h1-2H,(H2,9,11)

Upstream product

• 41667-95-2 5,6-dichloronicotinic acid 
• 54127-29-6 5,6-dichloronicotinoyl chloride 

Downstream Products

• 65189-15-3 5,6-dichloro-3-pyridinecarbonitrile 

Relevant articles and documents

METAL COMPLEXES, COMPRISING CARBENE LIGANDS HAVING AN O-SUBSTITUTED NON-CYCLOMETALATED ARYL GROUP AND THEIR USE IN ORGANIC LIGHT EMITTING DIODES

Cyclometallated Ir complex comprising three N,N diaryl substituted carbene ligands, bearing substituents in the 2 position of the non-cyclometallated aryl ring;an organic electronic device, preferably an organic light-emitting diode (OLED), comprising at least one cyclometallated Ir complexas described above, a light-emitting layer comprising said cyclometallated Ir complex preferably as emitter material, preferably in combination with at least one host material, use of said cyclometallated Ir complex in an OLED and an apparatus selected from the group consisting of stationary visual display units, mobile visualdisplay units, illumination units, units in items of clothing, units in handbags, units in accessoires, units in furniture and units in wallpaper comprising said organic electronic device, preferably said OLED, or said light-emitting layer. The present invention further relates to a process for the preparation of said cyclometallated Ir complex.

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme

The present invention relates to compounds which are inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, and other diseases and conditions that are mediated by excessive glucocorticoid action.